Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-08-31 Purchase |
2023-09-08 5:47 pm |
Arch Therapeutics Inc. | ARTH | ABRAMS MICHAEL S CHIEF FINANCIAL OFFICER |
10,292 | $0.275 | $2,830 | 30,876 (Direct) |
View |
| 2023-08-31 Purchase |
2023-09-08 5:47 pm |
Arch Therapeutics Inc. | ARTH | Norchi Terrence W PRESIDENT AND CHIEF EXECUTIVE |
6,862 | $0.275 | $1,887 | 20,586 (Direct) |
View |
| 2023-08-31 Purchase |
2023-09-08 5:47 pm |
Arch Therapeutics Inc. | ARTH | Hicks Laurence Director |
10,292 | $0.275 | $2,830 | 30,876 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-08-31 Option Award |
2023-09-08 5:47 pm |
N/A 2028-08-31 |
Arch Therapeutics Inc. | ARTH | ABRAMS MICHAEL S CHIEF FINANCIAL OFFICER |
20,584 | $0 | 30,876 (Direct) |
View |
| 2023-08-31 Option Award |
2023-09-08 5:47 pm |
N/A 2028-08-31 |
Arch Therapeutics Inc. | ARTH | Norchi Terrence W PRESIDENT AND CHIEF EXECUTIVE |
13,724 | $0 | 20,586 (Direct) |
View |
| 2023-08-31 Option Award |
2023-09-08 5:47 pm |
N/A 2028-08-31 |
Arch Therapeutics Inc. | ARTH | Hicks Laurence Director |
20,584 | $0 | 30,876 (Indirect) |
View |
| 2022-11-10 Option Award |
2022-11-10 9:54 pm |
N/A 2032-11-10 |
Arch Therapeutics Inc. | ARTH | DHILLON PUNIT Director |
250,000 | $0 | 250,000 (Direct) |
View |
| 2022-11-10 Option Award |
2022-11-10 9:52 pm |
N/A 2032-11-10 |
Arch Therapeutics Inc. | ARTH | Fish Guy L. Director |
250,000 | $0 | 250,000 (Direct) |
View |
| 2022-11-10 Option Award |
2022-11-10 9:51 pm |
N/A 2032-11-10 |
Arch Therapeutics Inc. | ARTH | Hicks Laurence Director |
250,000 | $0 | 250,000 (Direct) |
View |
| 2022-11-10 Option Award |
2022-11-10 9:50 pm |
N/A 2032-11-10 |
Arch Therapeutics Inc. | ARTH | Yrigoyen Dan VICE PRESIDENT, SALES |
500,000 | $0 | 500,000 (Direct) |
View |
| 2022-11-10 Option Award |
2022-11-10 9:50 pm |
N/A 2032-11-10 |
Arch Therapeutics Inc. | ARTH | Norchi Terrence W PRESIDENT AND CHIEF EXECUTIVE |
1,250,000 | $0 | 1,250,000 (Direct) |
View |
| 2022-11-10 Option Award |
2022-11-10 9:49 pm |
N/A 2032-11-10 |
Arch Therapeutics Inc. | ARTH | ABRAMS MICHAEL S CHIEF FINANCIAL OFFICER |
900,000 | $0 | 900,000 (Direct) |
View |
| 2022-07-06 Option Award |
2022-07-08 4:57 pm |
N/A N/A |
Arch Therapeutics Inc. | ARTH | ABRAMS MICHAEL S CHIEF FINANCIAL OFFICER |
868,998 | $0 | 868,998 (Direct) |
View |
| 2022-07-06 Option Award |
2022-07-08 4:55 pm |
N/A N/A |
Arch Therapeutics Inc. | ARTH | Norchi Terrence W PRESIDENT AND CHIEF EXECUTIVE |
579,332 | $0 | 13,488,409 (Direct) |
View |
| 2022-07-06 Option Award |
2022-07-08 4:53 pm |
N/A N/A |
Arch Therapeutics Inc. | ARTH | Hicks Laurence Director |
868,998 | $0 | 868,998 (Direct) |
View |
| 2022-05-24 Option Award |
2022-06-09 6:21 pm |
N/A 2032-05-23 |
Arch Therapeutics Inc. | ARTH | Yrigoyen Dan VICE PRESIDENT, SALES |
150,000 | $0 | 150,000 (Direct) |
View |
| 2021-12-31 Option Award |
2022-01-04 4:17 pm |
N/A 2031-12-31 |
Arch Therapeutics Inc. | ARTH | Fish Guy L. Director |
250,000 | $0 | 250,000 (Direct) |
View |
| 2021-09-27 Option Award |
2021-10-13 06:03 am |
N/A 2031-09-26 |
Arch Therapeutics Inc. | ARTH | Hicks Laurence Director |
250,000 | $0 | 250,000 (Direct) |
View |
Ownership |
2021-10-12 9:23 pm |
N/A N/A |
Arch Therapeutics Inc. | ARTH | Hicks Laurence Director |
0 | $0 | 527,273 (Indirect) |
View |
| 2021-09-27 Option Award |
2021-10-01 08:21 am |
N/A 2031-09-26 |
Arch Therapeutics Inc. | ARTH | Yrigoyen Dan Vice President, Sales |
200,000 | $0 | 200,000 (Direct) |
View |
| 2021-09-27 Option Award |
2021-10-01 08:17 am |
N/A 2031-09-26 |
Arch Therapeutics Inc. | ARTH | ABRAMS MICHAEL S Chief Financial Officer |
350,000 | $0 | 350,000 (Direct) |
View |
| 2021-09-27 Option Award |
2021-10-01 08:14 am |
N/A 2031-09-26 |
Arch Therapeutics Inc. | ARTH | SULAT JAMES R Director |
500,000 | $0 | 500,000 (Direct) |
View |
| 2021-09-27 Option Award |
2021-10-01 08:11 am |
N/A 2031-09-26 |
Arch Therapeutics Inc. | ARTH | DHILLON PUNIT Director |
500,000 | $0 | 500,000 (Direct) |
View |
| 2021-09-27 Option Award |
2021-10-01 08:06 am |
N/A 2031-09-26 |
Arch Therapeutics Inc. | ARTH | Norchi Terrence W President, CEO and Director |
2,000,000 | $0 | 2,000,000 (Direct) |
View |
| 2021-07-30 Option Award |
2021-08-11 5:17 pm |
N/A 2031-07-29 |
Arch Therapeutics Inc. | ARTH | Yrigoyen Dan Vice President, Sales |
150,000 | $0 | 300,000 (Direct) |
View |
Ownership |
2021-05-10 08:02 am |
N/A 2031-05-02 |
Arch Therapeutics Inc. | ARTH | ABRAMS MICHAEL S CFO and Treasurer |
0 | $0 | 500,000 (Direct) |
View |
| 2020-06-22 Exercise |
2020-06-23 07:59 am |
2015-06-30 2020-06-30 |
Arch Therapeutics Inc. | ARTH | SULAT JAMES R Director |
454,546 | $0 | 2,087,723 (Indirect) |
View |
| 2020-06-22 Exercise |
2020-06-23 07:59 am |
N/A N/A |
Arch Therapeutics Inc. | ARTH | SULAT JAMES R Director |
454,546 | $0.18 | 2,087,723 (Indirect) |
View |